that doesn’t include trial costs. Once trials start there will be higher spends for a few months IMO.
On the back of this if we can get partnerships for future funding that will be great.
Ann: Quarterly activities and cashflow report, page-3
Add COV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $30.19M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 95179 | 3 |
View Market Depth
| Last trade - 07.32am 06/11/2024 (20 minute delay) ? |
| COV (ASX) Chart |
Day chart unavailable